- Home
- HCSG vs AMLX Comparison
HCSG vs AMLX Comparison
Compare HCSG & AMLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HCSG | AMLX |
|---|---|---|
| Founded | 1976 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Assisted Living Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.5B |
| IPO Year | 1994 | 2021 |
Fundamental Metrics
Financial Performance| Metric | HCSG | AMLX |
|---|---|---|
| Price | $24.87 | $18.08 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 9 |
| Target Price | ★ $22.67 | $21.56 |
| AVG Volume (30 Days) | 729.3K | ★ 1.8M |
| Earning Date | 04-22-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 52.83 | ★ 65.46 |
| EPS | ★ 0.37 | N/A |
| Revenue | ★ $1,837,173,000.00 | $380,786,000.00 |
| Revenue This Year | $7.39 | N/A |
| Revenue Next Year | $5.22 | N/A |
| P/E Ratio | $67.97 | ★ N/A |
| Revenue Growth | 7.08 | ★ 1612.94 |
| 52 Week Low | $12.66 | $7.48 |
| 52 Week High | $25.55 | $19.15 |
Technical Indicators
Market Signals| Indicator | HCSG | AMLX |
|---|---|---|
| Relative Strength Index (RSI) | 78.53 | 69.75 |
| Support Level | $18.36 | $12.17 |
| Resistance Level | N/A | $18.61 |
| Average True Range (ATR) | 0.71 | 1.04 |
| MACD | 0.27 | 0.33 |
| Stochastic Oscillator | 89.87 | 83.43 |
Price Performance
Historical ComparisonAbout HCSG Healthcare Services Group Inc.
Healthcare Services Group Inc is a provider of housekeeping and facility management services to the healthcare industry. The company manages and evaluates its operations in two reportable segments: Environmental Services segment includes housekeeping, management of clients' housekeeping departments, cleaning, disinfecting and sanitizing, laundry, bed linen, and uniform services, linen and other services; and Dietary Segment includes dietary department services, food purchasing, meal preparation, and providing dietitian consulting services. Its clients are nursing homes, retirement complexes, rehabilitation centers, and hospitals in the United States of America. The Environmental Services segment derives maximum revenue.
About AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on developing novel therapies for communities with high unmet medical needs. The company has preclinical and clinical development programs in endocrine conditions and neurodegenerative diseases. Its pipeline includes investigational therapies matched with diseases based on mechanistic rationale, clinical outcomes, biomarkers, and preclinical data. The company is currently developing avexitide for Post-Bariatric Hypoglycemia, AMX0035 for Wolfram Syndrome, AMX0114 for Amyotrophic Lateral Sclerosis, and AMX0318 for Post-Bariatric Hypoglycemia and other rare diseases.